関連する実験動画
Updated: Sep 10, 2025

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.6K
脂質プロファイリングは,アルツハイマー病の女性の不飽和脂質の減少を明らかにします
Asger Wretlind1,2, Jin Xu1, Wenqiang Chen2,3
1King's College London, London, UK.
まとめ
アルツハイマー病 (AD) は,女性の異なる脂質プロファイルを示しています. コレステロールやアポリプロテインBとは関係なく,不飽和脂質が減少し,飽和脂質が増加した.
科学分野:
- 神経科学
- 生物化学
- ゲノミクス
背景:
- アルツハイマー病 (AD) は 女性に不釣り合いな影響を及ぼします
- 性別特有のADの危険因子やバイオマーカーの理解は極めて重要です
研究 の 目的:
- 単一の脂質とアルツハイマー病 (AD) の性別の関連性を調査する.
- 性別分別でADと脂質の関連性を調査する.
主な方法:
- AddNeuroMedコホートからの841人の参加者 (AD306人,MCI165人,対照370人) の血サンプルを分析した.
- 脂質モジュールと単一の脂質の性別関連が研究された.
- 原因を突き止めるために 調停分析を行いました
主要な成果:
- ADに関連した性別特有の脂質モジュールを特定した.
- 飽和脂肪酸の濃度が低下し,飽和脂肪酸の濃度が増加した.
- 不飽和のリンパ脂は,コレステロール,LDL,またはアポリポプロテインBとは独立してADに影響を与えました.
結論:
- 脂質プロファイリングは,主に女性でADに関連した変化を明らかにします.
- アルツハイマー病の女性は不飽和脂肪酸の濃度が低く,飽和脂肪酸の濃度が高くなります.
- 性別分別分析はADの様々な表れを理解するために不可欠です.
さらに関連する動画
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
978
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
7.9K
関連する概念動画
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Blood Studies for Cardiovascular System III: Serum Lipid Profile
293
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
293